Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
Follow-Up Questions
Who is the CEO of Uni-Bio Science Group Ltd?
Mr. Zhi Gang Zhao is the Chief Executive Officer of Uni-Bio Science Group Ltd, joining the firm since 2014.
What is the price performance of UNBSF stock?
The current price of UNBSF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Uni-Bio Science Group Ltd?
Uni-Bio Science Group Ltd belongs to Biotechnology industry and the sector is Health Care
What is Uni-Bio Science Group Ltd market cap?
Uni-Bio Science Group Ltd's current market cap is $0
